Franklyn Health, a rapidly growing leader in MedTech clinical research, has further cemented its industry reputation after being invited to judge at the prestigious MedTech Innovator Radar Forum — one of the most exclusive and competitive events in the global MedTech industry.

With only 8% of more than 1,800 applicants selected, the forum showcases 150 of the most promising MedTech start-ups, who present to a hand-picked panel of leading industry experts. Franklyn Health’s selection as a judge reflects the deep expertise, credibility, and rising demand for its clinical research, regulatory, and market access services.

Highly Skilled and In Demand Across the MedTech Industry

Representing Franklyn Health, Michael Branagan-Harris served as a value judge on the programme, evaluating and mentoring some of the world’s most exciting medical device and diagnostics companies across clinical strategy, regulatory affairs, and market access.

Being chosen to judge at an event of this calibre is a clear signal of Franklyn Health’s standing in the MedTech sector. A testament to the company’s growing influence and the increasing demand for its specialist expertise.

Purpose-Built for Emerging MedTech

Franklyn Health is purpose-built to partner with ambitious medical device and diagnostics manufacturers. The team specialises in developing clinical strategy, solving complex regulatory challenges, and bringing innovative new technologies to market, faster.

As demand for expert MedTech clinical research support continues to accelerate, Franklyn Health remains a trusted, in-demand partner for medical device and diagnostics companies worldwide — driving forward its position as one of the fastest-growing names in MedTech clinical research.

Franklyn Health’s role at the MedTech Innovator Radar Forum is the latest milestone in the company’s continued growth, reinforcing its reputation as a highly skilled, highly trusted, and increasingly in-demand leader in the global MedTech ecosystem.